PharmaCielo Ltd. (PCLO.V)
| Previous Close | 0.2650 |
| Open | 0.2750 |
| Bid | 0.2550 x 0 |
| Ask | 0.2750 x 0 |
| Day's Range | 0.2550 - 0.2750 |
| 52 Week Range | 0.1500 - 1.2200 |
| Volume | |
| Avg. Volume | 118,462 |
| Market Cap | 39.367M |
| Beta (5Y Monthly) | 2.75 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3450 |
| Earnings Date | Nov 28, 2022 - Dec 02, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.50 |
- CNW Group
PharmaCielo Announces Continued Progress on Efficiency Initiatives to Accelerate Profitability and Intention to Amend Warrant Terms
PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today provided a corporate update, regarding progress against the efficiency initiatives it began to implement in mid-2021, which are designed to accelerate the Company's path to profitability. The Company also announced its intention to amend exist
- CNW Group
PharmaCielo Receives First Commercial Purchase Order from Ease Labs Pharma - Proprietary API a Key Ingredient in Recently Approved Product for Brazilian Market
PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today announced that it has received its first commercial purchase order for API from Ease Labs Pharma ("Ease Labs"), a multinational, GMP certified pharmaceutical company headquartered in Brazil. PharmaCielo and Ease Labs have signed an ongoing sal
- CNW Group
PharmaCielo Announces First Shipment of Pharmaceutical Grade Cannabis Extract to Customer in Morocco
PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried cannabis flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today announced that it has made an initial shipment of CBD Isolate to a pharmaceutical company in Morocco, to facilitate pre-commercial testing. The customer is developing a portfolio of cannabinoid medicines, both non-psychoactive, and ps
